Clinical and experimental parameters
| Controls | First episode | t test | |
|---|---|---|---|
| Number of subjects | 20 | 18 | |
| Female | 5 | 4 | |
| Male | 15 | 14 | |
| Age (years) | 24.05 ± 3.99 | 21.61 ± 4.34 | t(36) = −1.88; p = 0.07 |
| Education (years) | 13.78 ± 2.51 | 14.17 ± 1.65 | t(36) = 0.55; p = 0.59 |
| Motion (mm) | 0.70 ± 0.26 | 0.68 ± 0.26 | t(36) = −0.22; p = 0.83 |
| TE (ms) | 85.84 ± 1.36 | 85.73 ± 1.28 | t(36) = −0.26; p = 0.80 |
| SNR (raw) | 12.06 ± 1.47 | 12.12 ± 1.58 | t(36) = 0.12; p = 0.91 |
| SNR filtered | 13.05 ± 1.14 | 13.22 ± 1.18 | t(36) = 0.46; p = 0.65 |
| CPZ (mg/d) | 472.24 ± 651.33 | ||
| Duration of illness (months) | 6.19 ± 4.27 | ||
| Duration of medication (months) | 4.04 ± 3.58 | ||
| Antipsychotic medication (typical/atypical/both/none) | 1/12/2/3 |
The t test column holds the t statistic (with degrees of freedom) and significance value, p, for an unpaired two-sample t test.